Plazomicin sulfate

Tier C — Watch / trade

Plazomicin sulfate

Ionis Pharmaceuticals Inc

Originator

2018

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：30S subunit

Brand：Zemdri

Indications (approved)：Bacterial infection, Hospital-acquired pneumonia, Urinary tract infection, Pyelonephritis, End-stage renal disease, 肠杆菌科感染, Ventilator-associated pneumonia, Healthcare-associated pneumonia

Regional status

Withdrawn

China

Japan

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Plazomicin sulfate?

Approved indications include: Bacterial infection, Hospital-acquired pneumonia, Urinary tract infection, Pyelonephritis, End-stage renal disease, 肠杆菌科感染, Ventilator-associated pneumonia, Healthcare-associated pneumonia.

When does the Plazomicin sulfate patent expire?

No public expiry year is available for Plazomicin sulfate yet; this page updates once verified.

How do I get a quote for Plazomicin sulfate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-28